Archives of Clinical Infectious Diseases
Infectious Diseases and Tropical Medicine Research Center, SBUMS
Authors
Rhinocerebral zygomycosis is a rare, rapidly progressive and often fatal fungal infection occurring in several immunocompromised states. Prior investigators have reported an increasing incidence among Iranian population; therefore, we decided to present the clinical features and treatment outcome of a group of patients with rhinocerebral zygomycosis.
Medical records of all cases with the diagnosis of rhinocerebral zygomycosis attending Rasoule- Akram Hospital, Tehran, Iran, were retrospectively reviewed from 1997 to 2007. Age, gender, predisposing illness, surgical procedures, and treatment outcomes were reviewed.
Totally, 30 patients (17 males and 13 females) were reviewed with a mean age of 49.420.3 years. The lag time between onset of symptoms referable to zygomycosis and commencement of amphotericin B was 1 to 90 days with median of 10 days. An association between delayed treatment and mortality was found (p=0.01). Visual loss was observed in 53.3%. The ethmoid (86.6%) and maxillary sinuses (66.6%) were most commonly involved. Eighteen patients had underlying diabetes mellitus (60%). All patients received medical treatment, while 28 (93.3%) underwent surgical intervention. Twenty three patients (76.7%) had orbital involvement with a mortality rate of 43.5%. The overall mortality rate was 40% (12 cases). Patients with higher doses of amphotericin B and multiple surgical intervention had lower mortality rate (p=0.00 and p=0.01, respectively). Factors such as age, gender, predisposing diseases, orbital involvement, multi-sinus involvement, and white blood cell count had no impact on survival rate.
Institution of aggressive surgical debridement of devitalized tissue and the timely initiation of systemic medical therapy is critical for good outcome.
© 2010, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Arian M, Aeen S, Bojdi A, Jabbari Nooghabi M, Tajik A, et al. Improving the Outcome of Patients Diagnosed with Rhino-orbito-cerebral Mucormycosis in the Last Two Decades: 97 Patients in Two Referral Centers in the Northeast of Iran. Arch Clin Infect Dis. 2024;19(5):e151510. doi: https://doi.org/10.5812/archcid-151510
Nashibi R, Afzalzadeh S, Mohammadi MJ, Yari AR, Yousefi F. Epidemiology and Treatment Outcome of Mucormycosis in Khuzestan, Southwest of Iran. Arch Clin Infect Dis. 2017;12(1):e37221. doi: https://doi.org/10.5812/archcid.37221
Naeimi Eshkaleti M, Hashemi SJ, Falahati M, Mahmoudi S, Zaini F, et al. Molecular Identification of Causative Agents in 25 Cases with Mucormycosis in Iran. Arch Clin Infect Dis. 2019;14(1):e69100. doi: https://doi.org/10.5812/archcid.69100
Mardani M, Yadegarynia D, Tehrani S. Combination Antifungal Treatment for Sino-Orbito-Cerebral Mucormycosis: A Case Report. Arch Clin Infect Dis. 2016;11(1):e28345. doi: https://doi.org/10.5812/archcid.28345
Cheraghsahar S, Kazemi S, Birjandi M, Yarahmadi M, Mahmoudi S, et al. Otomycosis in Western Iran: Clinical and Mycological Aspects. Arch Clin Infect Dis. 2017;12(2):e57287. doi: https://doi.org/10.5812/archcid.57287
More by these authors
Last Update: 3 weeks ago
Last Update: 3 weeks ago
Last Update: 3 weeks ago
Last Update: 4 hours ago
Last Update: 1 day ago
Last Update: 4 days ago
